- Discusses Recent EPA Registration for SteraMist™ Binary Ionization Technology® (BIT™) -
- Provides Business Update and Strategic Outlook -
BEVERLY HILLS, Calif., June 30, 2015 (GLOBE NEWSWIRE) -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, will hold a conference call today at 4:30 p.m. Eastern Time to review the company's recent business highlights and answer questions.
Among the topics covered, TOMI's Chief Executive Officer Dr. Halden Shane will review the registration of its SteraMist™ with Binary Ionization Technology® (BIT™) with the Environmental Protection Agency (EPA) for use in hospitals and healthcare facilities under the EPA's new fogging and misting protocol, as originally announced on June 24, 2015.
Dr. Halden Shane, TOMI's Chief Executive Officer, stated: "We continue to make significant progress in addressing the large-scale opportunities in the infection control market, as demonstrated by the recent EPA registration of our SteraMist™ product. SteraMist, which leverages our patented Binary Ionization Technology® (BIT™), offers distinct advantages in speed and efficacy over competing household and industrial cleaners. I am more encouraged than ever about our ability to bring our leading, cutting-edge technology to market in rapid fashion."
Conference Call Information
To listen to the call, please dial 1-888-339-0752 or 1-412-902-4193, passcode #10067311. To listen to the webcast or view the press release, please visit the Investor Relations section of the TOMI website at: http://www.tomiesinc.com/us/investors/.
The replay can be accessed for up to 24 hours starting at 8:00 p.m. ET the day of the call by dialing 1-877-344-7529 or 1-412-317-0088, passcode #10067311. A replay of the webcast will be available for at least 90 days on the company's website, starting approximately one hour after the completion of the call.
About TOMI™ Environmental Solutions, Inc.
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology® (BIT™), a state of the art technology for the production of its six-log mist represented by the TOMI™ SteraMist™ brand.
TOMI's products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI's products and services have also been used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit www.tomiesinc.com or contact us at info@tomiesinc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.